logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation.

    Article - En anglais

    We determined the polymorphic N-acetyltransferase 2 (NAT2) genotype of 124 patients with non-small-cell lung cancer (NSCLC) and 376 control subjects using a PCR-based assay.

    The slow acetylator genotype was present in 17 (14%) of 124 NSCLC patients and in 40 (11%) of 376 control subjects.

    The relative risk of slow acetylators compared with rapid acetylators in patients with adenocarcinoma was 2.01 (p=0.05).

    This trend was more marked when the analysis was confined to patients under the age of 65 (relative risk, 2.7 ; p=0.03).

    No such trend was identified in patients with squamous cell carcinoma.

    We also determined the incidence of p53 gene mutations to investigate the possibility of a link between this gene mutation and N-acetylation polymorphism.

    There was no significant association between p53 gene mutations and NAT2 polymorphism in the overall NSCLC group.

    However, the incidence of p53 mutations in adenocarcinoma patients under the age of 65 who had the slow acetylator genotype was 63% compared with 38% in patients with the rapid or intermediate acetylator genotype.

    These findings suggest that the slow acetylator phenotype may be linked to the impaired metabolism of a carcinogen that predisposes individuals to p53 gene mutations, and thus may be associated with an increased risk of pulmonary adenocarcinoma.

    Mots-clés Pascal : Adénocarcinome, Carcinome épidermoïde, Bronchopulmonaire, Phénotype acétylateur, Carcinogenèse, Epidémiologie, Réaction chaîne polymérase, DNA, Enzyme, Polymorphisme, Acétylation, Homme, Gène suppresseur tumeur, Gène TP53, Mutation, Appareil respiratoire pathologie, Poumon pathologie, Bronche pathologie, Tumeur maligne, Carcinome non petite cellule, Biologie moléculaire, N-acetyltransferase

    Mots-clés Pascal anglais : Adenocarcinoma, Squamous cell carcinoma, Bronchopulmonary, Acetylator phenotype, Carcinogenesis, Epidemiology, Polymerase chain reaction, DNA, Enzyme, Polymorphism, Acetylation, Human, Tumor suppressor gene, TP53 Gene, Mutation, Respiratory disease, Lung disease, Bronchus disease, Malignant tumor, Non small cell carcinoma, Molecular biology

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0184764

    Code Inist : 002B11A. Création : 21/05/1997.